[68GA]GA-L21

N/A

Report date: 2025/10/20 17:51:41

NME

Base Information

Drug Name[68GA]GA-L21

Drug Alias NameN/A

ClassificationRadiation-emitting products > Nuclides > Gallium > 68GaRadiation-emitting products > Radioactive therapeutic agentRadiation-emitting products > Radionuclide Drug Conjugates

Mechanisms of ActionIntegrin alpha-V/beta-3 modulatorsAminopeptidase N modulatorsAlbumins modulators

TargetsIntegrin alpha-V/beta-3Aminopeptidase NAlbumins

Therapy Area/IndicationsNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryMainland China

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaPreclinical

Originator CompaniesHexin (Suzhou) Pharmaceutical Technology Co Ltd

China Registration ClassN/A

Develop Information

Active CompaniesHexin (Suzhou) Pharmaceutical Technology Co Ltd

Inactive CompaniesN/A

Active IndicationsNeoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A